217 related articles for article (PubMed ID: 37353784)
1. m
Fang H; Sun Q; Zhou J; Zhang H; Song Q; Zhang H; Yu G; Guo Y; Huang C; Mou Y; Jia C; Song Y; Liu A; Song K; Lu C; Tian R; Wei S; Yang D; Chen Y; Li T; Wang K; Yu Y; Lv Y; Mo K; Sun P; Yu X; Song X
Mol Cancer; 2023 Jun; 22(1):99. PubMed ID: 37353784
[TBL] [Abstract][Full Text] [Related]
2. WT1-AS/IGF2BP2 Axis Is a Potential Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma According to ceRNA Network Comprehensive Analysis Combined with Experiments.
Jia M; Shi Y; Xie Y; Li W; Deng J; Fu D; Bai J; Ma Y; Zuberi Z; Li J; Li Z
Cells; 2021 Dec; 11(1):. PubMed ID: 35011587
[TBL] [Abstract][Full Text] [Related]
3. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
[TBL] [Abstract][Full Text] [Related]
4. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway.
Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H
Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503
[TBL] [Abstract][Full Text] [Related]
5. LncRNA HCG11 mediated by METTL14 inhibits the growth of lung adenocarcinoma via IGF2BP2/LATS1.
Mao J; Qiu H; Guo L
Biochem Biophys Res Commun; 2021 Nov; 580():74-80. PubMed ID: 34624573
[TBL] [Abstract][Full Text] [Related]
6. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
Zhao W; Xie Y
Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
[TBL] [Abstract][Full Text] [Related]
7. Effects of N6-Methyladenosine Regulators on LAG3 and Immune Infiltrates in Lung Adenocarcinoma.
Wang N; Xu Y; Jin L; Wang X; Wu S; Wang Y; Zhao J; Zhou F; Ge H
Dis Markers; 2022; 2022():1829528. PubMed ID: 36051357
[TBL] [Abstract][Full Text] [Related]
8. Multi-omics immune regulatory mechanisms in lung adenocarcinoma metastasis and survival time.
Liu D; Yao L; Ding X; Zhou H
Comput Biol Med; 2023 Sep; 164():107333. PubMed ID: 37586202
[TBL] [Abstract][Full Text] [Related]
9. COL3A1-positive endothelial cells influence LUAD prognosis and regulate LUAD carcinogenesis by NCL-PI3K-AKT axis.
Zhang M; Liang Y; Song P
J Gene Med; 2024 Jan; 26(1):e3573. PubMed ID: 37547956
[TBL] [Abstract][Full Text] [Related]
10. Single-cell transcriptome analysis demonstrates inter-patient and intra-tumor heterogeneity in primary and metastatic lung adenocarcinoma.
Liu Y; Ye G; Huang L; Zhang C; Sheng Y; Wu B; Han L; Wu C; Dong B; Qi Y
Aging (Albany NY); 2020 Nov; 12(21):21559-21581. PubMed ID: 33170151
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Impact of
Guo W; Huai Q; Wan H; Guo L; Song P; Gao S; He J
DNA Cell Biol; 2021 Feb; 40(2):316-331. PubMed ID: 33493403
[TBL] [Abstract][Full Text] [Related]
12. Multi-scale integrative analyses identify THBS2
Yang H; Sun B; Fan L; Ma W; Xu K; Hall SRR; Wang Z; Schmid RA; Peng RW; Marti TM; Gao W; Xu J; Yang W; Yao F
Theranostics; 2022; 12(7):3104-3130. PubMed ID: 35547750
[No Abstract] [Full Text] [Related]
13. LncRNA surfactant associated 1 activates large tumor suppressor kinase 1/Yes-associated protein pathway via modulating hypoxic exosome-delivered miR-4766-5p to inhibit lung adenocarcinoma metastasis.
Zhang W; Bai M; Liu K; Tan J; Ma J; Zhao J; Hou P
Int J Biochem Cell Biol; 2022 Dec; 153():106317. PubMed ID: 36283586
[TBL] [Abstract][Full Text] [Related]
14. The essential roles of m
Ma L; Xue X; Zhang X; Yu K; Xu X; Tian X; Miao Y; Meng F; Liu X; Guo S; Qiu S; Wang Y; Cui J; Guo W; Li Y; Xia J; Yu Y; Wang J
J Exp Clin Cancer Res; 2022 Jan; 41(1):36. PubMed ID: 35078505
[TBL] [Abstract][Full Text] [Related]
15. M2 macrophage-derived exosomes promote lung adenocarcinoma progression by delivering miR-942.
Wei K; Ma Z; Yang F; Zhao X; Jiang W; Pan C; Li Z; Pan X; He Z; Xu J; Wu W; Xia Y; Chen L
Cancer Lett; 2022 Feb; 526():205-216. PubMed ID: 34838826
[TBL] [Abstract][Full Text] [Related]
16. WTAP-mediated N6-methyladenine Modification of circEEF2 Promotes Lung Adenocarcinoma Tumorigenesis by Stabilizing CANT1 in an IGF2BP2-dependent Manner.
Zheng H; Cao Z; Lv Y; Cai X
Mol Biotechnol; 2024 Apr; ():. PubMed ID: 38619801
[TBL] [Abstract][Full Text] [Related]
17. Systematic Analysis of the Expression Profile and Prognostic Significance of the IGF2BP Family in Lung Adenocarcinoma.
Zhou Z; Zhu T; Chen S; Qin S; Huang Y; Liu D
Curr Cancer Drug Targets; 2022; 22(4):340-350. PubMed ID: 35232349
[TBL] [Abstract][Full Text] [Related]
18. SAM68 promotes tumorigenesis in lung adenocarcinoma by regulating metabolic conversion via PKM alternative splicing.
Zhu S; Chen W; Wang J; Qi L; Pan H; Feng Z; Tian D
Theranostics; 2021; 11(7):3359-3375. PubMed ID: 33537092
[No Abstract] [Full Text] [Related]
19. Unique metastasis-associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma.
Zhang X; Han J; Du L; Li X; Hao J; Wang L; Zheng G; Duan W; Xie Y; Zhao Y; Zhang X; Zou M; Wang C
Thorac Cancer; 2020 Mar; 11(3):728-737. PubMed ID: 31994347
[TBL] [Abstract][Full Text] [Related]
20. N6-methyladenosine reader YTH N6-methyladenosine RNA binding protein 3 or insulin like growth factor 2 mRNA binding protein 2 knockdown protects human bronchial epithelial cells from hypoxia/reoxygenation injury by inactivating p38 MAPK, AKT, ERK1/2, and NF-κB pathways.
Xiao K; Liu P; Yan P; Liu Y; Song L; Liu Y; Xie L
Bioengineered; 2022 May; 13(5):11973-11986. PubMed ID: 34709120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
